Doctors hail breakthrough on diabetes

THOUSANDS of Scots living with a killer condition have been offered hope by a new treatment.

Loading Comments
Share
Print

A drug has been approved for Type 2 diabetes patients who are unable to control blood sugar levels with diet or other medication.

Figures show around half (44.4%) of people diagnosed with the condition are failing to achieve the recommended blood glucose levels.

Canagliflozin is a once-daily tablet, which blocks the reabsorption of glucose in the kidneys meaning it is excreted in the urine, reducing levels significantly.

Uncontrolled Type 2 diabetes is associated with around 9,000 deaths each year in Scotland, mainly from cardiovascular disease, and kidney failure.

There are more than 48,000 people living in Glasgow with the condition and more than 11,000 are thought to be undiagnosed.

Its prevalence is increasing throughout Scotland.

Professor Miles Fisher, Consultant Physician at Glasgow Royal Infirmary said: "Type 2 diabetes is one of the most significant health challenges facing Scotland today,

"Gaining access to new treatments like canagliflozin, is important in helping us to better manage this deadly epidemic."

A new daily treatment for Hepatitis C - a major cause of liver cancer and death - has also been approved by the Scottish Medicines Consortium.

Sofosbuvir was been shown in clinical trials to offer cure rates of over 90% in some patients, when used in combination with other antiviral treatments over 12 weeks.

While hepatitis C can be cured, up until now many patients have been unwilling to endure the side effects of standard treatments.

In Scotland, since 1996, liver-related deaths among people with hepatitis C have increased three-fold, with deaths now exceeding those associated with HIV.

Mortality rates are expected to continue to rise.

However, Scots patients suffering from pancreatic cancer will not get access to a drug that has been approved south of the Border.

Abraxane (paclitaxel) was not recommended for use, despite some trials demonstrating a significant increase in overall survival compared to the current treatment.

Only around one in six patients with advanced disease survive for one year after diagnosis.

The treatment is available in England through the Cancer Drugs Fund.

Health

Commenting & Moderation

We moderate all comments on Evening Times on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.

166706

Have you got a story?

Contact the news desk on 0141 302 6520 or email news@eveningtimes.co.uk
Games news:

Putting the world to rights

Gail's Gab

Well done John Barrowman for redefining the Glasgow kiss at the opening ceremony.

Times Out

Entertainment

Lifestyle

TV Advert
Cat’s Eyes on Glasgow

Cat’s Eyes on Glasgow

Cat Cubie’s job is to find and share with you the fabulous things the city has to offer, from gigs to gastro.

Janice Bell

Janice Bell

You Couldn't Make This Up

Cold blooded approach to enjoy Saturday night fever

Michelle McManus

Michelle McManus

Columnist Michelle McManus is Sussed in the City, and loves to chat about anything and everything.